首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Advances in kidney disease and health

缩写:ADV KIDNEY DIS HEAL

ISSN:2949-8147

e-ISSN:2949-8139

IF/分区:3.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引211
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jing Miao,Charat Thongprayoon,Wisit Cheungpasitporn Jing Miao
Artificial intelligence (AI) and large language models are increasingly reshaping nephrology education. This review advances a hierarchical framework for understanding AI in nephrology education. At the primary level, AI may represent a sca...
Prakash Gudsoorkar,Paul E Hanna,Priti Meena et al. Prakash Gudsoorkar et al.
Cancer therapies have reshaped survival, but have also unmasked hypertension as a common and clinically significant complication with distinct underlying mechanisms. This review uniquely integrates mechanistic insights, particularly those r...
Geonte G Jackson,James M Luther,Matthew R Alexander Geonte G Jackson
Despite the current therapeutic options including lifestyle modifications and pharmacotherapy, blood pressure remains inadequately controlled in the majority of hypertensive individuals. Several new medications have been recently Food and D...
Patrick Hofmann,Danielle L Saly Patrick Hofmann
Hyperammonemia is a rare but life-threatening disorder that arises from hepatic and diverse nonhepatic etiologies and demands prompt physiologic evaluation and intervention to prevent neurologic injury. This review highlights the physiologi...
Ekamol Tantisattamo,Elaine Ku Ekamol Tantisattamo
As one of the known modifiable risk factors for cardiovascular disease, hypertension control is an attractive strategy for mitigating the risk of chronic kidney disease progression and cardiovascular disease. However, trial data have not al...
Sean Connolly,Abbas Zaidi,Carissa M Baker-Smith Sean Connolly
Pediatric hypertension is prevalent in 4% of children and is mainly of primary origin. Risk factors for primary pediatric hypertension extend beyond individual risk and include the social determinants of health. Addressing the presence of p...
Kevin Murphy,Elaine Peplow,Holly Kramer Kevin Murphy
Existing recommendations for blood pressure goals and treatment accumulated from decades of clinical trials and observational studies in which a resting blood pressure was measured in an outpatient setting and participants were followed for...
Stefanie Parisien-La Salle,Athira Puthukara,Anand Vaidya et al. Stefanie Parisien-La Salle et al.
Endocrine hypertension refers to elevated blood pressure resulting from an identifiable hormonal cause that is potentially treatable. Endocrine hypertension occurs in ∼30% of young adults with hypertension (18-40 years), in 30-50% of patie...
Emily L Simms,Gregory L Hundemer Emily L Simms
Primary aldosteronism (PA) is the most common and modifiable form of secondary hypertension, being responsible for 5-10% of all cases of hypertension and over 20% of cases of resistant hypertension. PA is characterized by autonomous aldoste...
Sayna Norouzi,Zohreh Gholizadeh Ghozloujeh,Edgar Lerma et al. Sayna Norouzi et al.
Fabry disease is a rare, X-linked lysosomal storage disorder caused by deficient α-galactosidase A activity, leading to progressive accumulation of globotriaosylceramide in multiple tissues. Its estimated incidence ranges from 1 in 40,000 ...